Search filters

List of works by Gregory R. Pond

"PSA-itis": knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancer

scientific article published in December 2002

A Phase 2 study of perifosine in advanced or metastatic breast cancer

scientific article published on 26 April 2007

A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer

scientific article published on 9 October 2015

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors

scientific article

A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer

scientific article published on 2 May 2017

A multicenter phase II study of "adjuvant" irinotecan following resection of colorectal hepatic metastases

scientific article published in December 2005

A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma

scientific article

A phase I study of pegylated liposomal doxorubicin hydrochloride (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small-cell lung cancer

scientific article published on September 2003

A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium

scientific article published on September 2009

A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.

scientific article published on 15 December 2016

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.

scientific article published on 18 March 2014

A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer

scientific article published on 05 January 2021

A prospective intervention to improve happiness and reduce burnout in oncologists

scientific article published on 30 November 2018

A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment

scientific article published in 2022

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

scientific article published on 03 October 2020

A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients

scientific article published on 07 August 2019

Ability of C‐reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel‐based chemotherapy

scientific article published on April 23, 2012

Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer

scientific article published in May 2008

Analysis of treatment practices for elderly cancer patients in Ontario, Canada

scientific article

Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns

scientific article published in December 2003

Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel

scientific article published on 20 October 2015

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.

scientific article published on 22 November 2017

Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer

scientific article

Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer

scientific article published on 06 April 2012

Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital

scientific article

Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy

scientific article published on 20 September 2012

Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma

scientific article published in December 2002

Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population

scientific article published on 16 November 2020

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study

scientific article published on 09 March 2019

Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy

scientific article published on 23 September 2014

Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis.

scientific article

Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study

scientific article published on 2 November 2015

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

scientific article

Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma.

scientific article published on 2 October 2014

Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma

scientific article published on 27 March 2014

Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A phase I-II study

scientific article published in March 2007

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

scientific article published on 01 March 2020

Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review

scientific article published on December 12, 2011

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study

scientific article

Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction

scientific article

Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

scientific article published on 13 September 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study

scientific article published in January 2008

Early stopping rules in oncology: considerations for clinicians.

scientific article published on 16 June 2011

Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective Studies

scientific article published on 27 December 2017

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases

scientific article

Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis

scientific article

Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials

scientific article published on 01 May 2012

Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer

scientific article published on June 22, 2011

Evaluating the feasibility of performing window of opportunity trials in breast cancer.

scientific article

Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination

scientific article published on 01 April 2006

Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib

scientific article

Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer

scientific article published on 01 September 2007

Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma

article

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors

scientific article published on 18 June 2020

Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib

scientific article published on August 2009

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

scientific article published in January 2005

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents

scientific article published on October 2006

Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design

scientific article published on 22 June 2013

Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma

scientific article published on 17 August 2015

Improving the quality of abstract reporting for phase I cancer trials

scientific article published in March 2008

Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design

scientific article published on 7 November 2014

Influence of censoring on conclusions of trials for women with metastatic breast cancer

scientific article

Influence of statistician involvement on reporting of randomized clinical trials in medical oncology

scientific article published on March 2013

Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 27 May 2016

Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population

scientific article published in April 2006

Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases

scientific article

Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital

scientific article published on February 2008

Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer

scientific article published on 19 September 2012

Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma

scientific article published on 21 January 2015

Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents

scientific article published in March 2008

Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration

scientific article published in 2021

Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation

scientific article published in 2008

Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy

scientific article

PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study.

scientific article published on June 2017

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.

scientific article published on 10 June 2014

Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial

scientific article published on 08 May 2006

Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy

scientific article published on 27 October 2017

Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending

scholarly article

Phase 1 trial design: is 3 + 3 the best?

scientific article

Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors

scientific article published on 01 August 2007

Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors

scientific article

Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study

scientific article published on 01 June 2007

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology

Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck

scientific article

Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma

scientific article published in August 2007

Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy

scientific article published on 18 September 2013

Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.

scientific article published on June 2013

Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib

scientific article published on June 2007

Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort

scientific article published on 17 April 2018

Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer

scientific article published on 15 March 2014

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.

scientific article published on 20 December 2016

Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis

scientific article

Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer.

scientific article published on 14 February 2018

Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.

scientific article

Radiation therapy for Bowen's disease of the skin

scientific article

Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer

scientific article published on 17 July 2014

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

scientific article published on 13 June 2014

Randomized phase II trials: inevitable or inadvisable?

scientific article published on 20 April 2010

Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients

scientific article published on 09 August 2019

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

scientific article published on 10 November 2020

Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer--At What Cost? Eur Urol 2016;69:642-44: Combination Chemotherapy as a Viable Salvage Therapy Strategy for Advanc

scientific article published on 23 September 2015

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology

scientific article published on 01 February 2019

Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy

scientific article published on 02 October 2010

Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.

scientific article published on 8 August 2015

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

scientific article published in February 2005

Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate.

scientific article published on 8 April 2017

Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study.

scientific article published on 13 April 2018

Statistical and analytical approaches for assessing biomarkers: New approaches, new technologies, with the same-old rigor for evaluation

scientific article published on January 16, 2012

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial

scientific article

The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis

scientific article

The association between radiographic response and overall survival in men with metastatic castration‐resistant prostate cancer receiving chemotherapy

scientific article published on September 1, 2011

The contents and readability of informed consent forms for oncology clinical trials

The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial

The influence of mentorship on research productivity in oncology

scientific article published in October 2007

The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer

scientific article published on 5 October 2013

The unclear zone in phase II clinical trials

scientific article published on 26 June 2010

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials

scientific article

Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status

scientific article

Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.

scientific article published on 31 December 2015

Trends in the application of dynamic allocation methods in multi-arm cancer clinical trials

scientific article published on 20 April 2010

Trial marketing in the Pan-Canadian Early Detection of Lung Cancer Study

scientific article published on 02 January 2020

UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: a study of the Princess Margaret Hospital Phase II consortium

scientific article